Plum Alley Investments

Plum Alley Investments is a venture capital firm based in New York, founded in 2012. The firm focuses on investing in early-stage, high-growth technology and healthcare companies that have at least one woman founder from the STEM fields. Plum Alley targets sectors such as smart hardware, intelligent machines, connected networks, agriculture technology, automation, safety, digital health, and longevity. By supporting advanced technologies and medical innovations, the firm aims to disrupt significant markets and create substantial value for society and the economy. As of April 2021, Plum Alley has invested over $35 million in 24 companies, fostering a diverse portfolio that emphasizes the importance of gender diversity in entrepreneurship.

Elise Lelon

Managing Director

KP Sunil Rao

COO, Plum Alley Ventures Company ; SVP Finance Plum Alley Ventures Company

Benjamin Robbins

Senior Associate Plum Alley Ventures Company

Liz Walsh

Managing Director, Plum Alley Ventures Company

Frances Walton

Partner

Alicia Zheng

Associate Plum Alley Ventures Company

36 past transactions

AiFi

Series B in 2022
AiFi provides a flexible AI platform that enables retailers to affordably deploy and scale autonomous shopping solutions across their businesses. Leveraging computer vision, AiFi adapts to existing store formats without the need for shelf sensors and provides advanced tracking algorithms that can scale up to 10,000 square feet to support various shopper journeys such as an app, credit card, gated, or hybrid entry. AiFi works with retailers worldwide such as ALDI South Group, Carrefour, Compass Group, Morrisons, Żabka Group, REWE, and Verizon. AiFi has the highest number of computer vision-powered autonomous stores across the globe. The company has raised a total of $80 million from investors including Verizon Ventures, Qualcomm Ventures, HP Tech Ventures, Mithril Capital, Cervin Ventures, TransLink Capital, Plum Alley, Duke Angel Network, Reaction, GS Future, Drive Catalyst, and Evolution. For more information, please visit aifi.com.

Gameto

Series A in 2022
Gameto is a biotechnology company whose mission is to redefine female reproductive health by developing therapies that improve lives. Women’s health is a vastly underserved therapeutic area. Most conditions have few treatment options, and those available often cause frequent complications and offer limited clinical benefit. Gameto aims to change that. Gameto is committed to using cutting-edge scientific advances to deliver better solutions to patients. Using cellular engineering, they have developed a platform to produce female reproductive cell lines. They use proprietary combinations of transcription factors to reprogram hiPSCs into engineered ovarian and endometrium cell lines that mimic the functions of endogenous cells, producing and responding to all hormones. Their team of cellular engineers is using this platform to advance a portfolio of cellular therapeutics for female reproductive diseases. Gameto's first program, Fertilo, is a therapeutic for IVF and egg freezing, aiming to make the process shorter, safer and more effective. Additional applications of our platform include, an organoid of the female reproductive system, Deovo, and a cell-based therapeutic to ameliorate the health consequences of primary ovarian insufficiency and menopause, Ameno.

Helaina

Series A in 2021
Helaina is a biotechnology company that produces milk-equivalent baby formula to offer breast milk alternatives. It produces bioactive proteins through fermentation to offer a new category of functional food products with immune benefits and nutritional options closest to breast milk. Its technology platform replicates functional proteins found in the human body, making them available as new nutrients.

Mammoth Biosciences

Series D in 2021
Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. Mammoth Biosciences aims to democratize disease detection with an easy and affordable point-of-care test that allows real-time and simultaneous detection of multiple conditions. By leveraging its internal research and development and exclusive licensing to Cas12, Cas13, and Cas14, Mammoth Biosciences can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in South San Francisco, Mammoth Biosciences is co-founded by CRISPR pioneer Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Mayfield, NFX, and 8VC, Decheng Capital and leading individual investors including Brook Byers, Tim Cook, and Jeff Huber. Mammoth has also been working on developing a rapid COVID-19 test.

Einride

Series B in 2021
Einride is a freight technology company providing digital, electric, and autonomous shipping. It was founded in 2016 and became the world’s first company to operate an autonomous, electric freight vehicle on a public road in 2019. Einride´s award-winning technology and products enable users to execute on electrification and automation, order and track shipments, oversee routes and assignments, visualize data and gain insights.

Bitwise Industries

Series B in 2021
Bitwise Industries moves Fresno’s technology ecosystem forward by focusing on the key areas of education, execution, and place. Education is delivered via Geekwise Academy, an accelerated training program providing real-world technology skills to all ages. Bitwise Industries provides execution by way of its full-service, custom software development firm, Shift3 Technologies. Bitwise Industries also offers paid apprenticeships to students to help them learn tech skills, connect them to meaningful tech opportunities, and build vibrant buildings in underserved cities to house their work.

Ashvattha Therapeutics

Series B in 2021
Ashvattha Therapeutics creates products that selectively target and treat human diseases. Ashvattha enables precision targeting for therapeutics eliminating off-target toxicity, systemic side effects, and immunogenicity seen in other platforms. Ashvattha has a pipeline of nine therapeutics in neurology, oncology, and ophthalmology.

Air Protein

Series A in 2021
Air Protein is a startup that aims to develop sustainable protein made from thin air. Using a proprietary probiotic process, Air Protein develops protein-enriched food made from CO2. This new source can be used to make meat-free burgers, protein-enriched pasta, cereals, beverages, and more.

Aclima

Series B in 2020
Aclima is a climate-tech company that focuses on mapping and analyzing air pollution through advanced measurement and analysis platforms. Aclima measures air pollution and greenhouse gases at unprecedented scales and block-by-block resolution. Their professional analytics software, Aclima Pro, translates billions of scientific measurements into environmental intelligence for governments, companies, and communities. Aclima is a purpose-driven technology company catalyzing bold climate action that protects public health, reduces emissions, and delivers clean air for all—investors, including Social Capital, Kapor Capital, and the Microsoft Climate Innovation Fund back them.

Ketos

Series B in 2020
KETOS is a vertically integrated water intelligence platform with intelligent hardware, bi-directional connectivity infrastructure, interactive software, and hassle-free services, all for a predictable, flat service fee. The company provides hardware and software analytics solutions and real-time data for usage and flow across water systems and monitors water health parameters such as pH, dissolved solids, hardness, turbidity, and salinity.

AiFi

Funding Round in 2020
AiFi provides a flexible AI platform that enables retailers to affordably deploy and scale autonomous shopping solutions across their businesses. Leveraging computer vision, AiFi adapts to existing store formats without the need for shelf sensors and provides advanced tracking algorithms that can scale up to 10,000 square feet to support various shopper journeys such as an app, credit card, gated, or hybrid entry. AiFi works with retailers worldwide such as ALDI South Group, Carrefour, Compass Group, Morrisons, Żabka Group, REWE, and Verizon. AiFi has the highest number of computer vision-powered autonomous stores across the globe. The company has raised a total of $80 million from investors including Verizon Ventures, Qualcomm Ventures, HP Tech Ventures, Mithril Capital, Cervin Ventures, TransLink Capital, Plum Alley, Duke Angel Network, Reaction, GS Future, Drive Catalyst, and Evolution. For more information, please visit aifi.com.

Ashvattha Therapeutics

Convertible Note in 2020
Ashvattha Therapeutics creates products that selectively target and treat human diseases. Ashvattha enables precision targeting for therapeutics eliminating off-target toxicity, systemic side effects, and immunogenicity seen in other platforms. Ashvattha has a pipeline of nine therapeutics in neurology, oncology, and ophthalmology.

Diligent Robotics

Series A in 2020
Diligent Robotics develops technically advanced robots with mobile manipulation, social intelligence, and human-guided learning capabilities to collaborate with and adapt to humans in everyday environments. Diligent Robotics' service robots are designed to participate and work together with teams of humans. The company's first product, Moxi, is a hospital robot assistant that helps clinical staff with logistical tasks, allowing them to have more time on direct patient care, improving patient satisfaction, quality of service, and safety.

Mammoth Biosciences

Series B in 2020
Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. Mammoth Biosciences aims to democratize disease detection with an easy and affordable point-of-care test that allows real-time and simultaneous detection of multiple conditions. By leveraging its internal research and development and exclusive licensing to Cas12, Cas13, and Cas14, Mammoth Biosciences can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in South San Francisco, Mammoth Biosciences is co-founded by CRISPR pioneer Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Mayfield, NFX, and 8VC, Decheng Capital and leading individual investors including Brook Byers, Tim Cook, and Jeff Huber. Mammoth has also been working on developing a rapid COVID-19 test.

Einride

Series A in 2019
Einride is a freight technology company providing digital, electric, and autonomous shipping. It was founded in 2016 and became the world’s first company to operate an autonomous, electric freight vehicle on a public road in 2019. Einride´s award-winning technology and products enable users to execute on electrification and automation, order and track shipments, oversee routes and assignments, visualize data and gain insights.

Evrnu

Series A in 2019
Evrnu is a textile innovations company producing engineered fiber made from discarded clothing. Its multiple lifecycle fiber technologies are used to create engineered fibers with extra environmental advantages that create a circular ecosystem.

Node

Venture Round in 2019
Node, recently acquired by SugarCRM, fuels Sugar's time-aware CX platform to help businesses by automatically forecasting expected outcomes and highlighting previously unforeseen challenges and opportunities. Extending Sugar’s time-aware CX platform, Node’s AI technology adds the most coveted element of time—the future. The combined solution offers wide-ranging capabilities for sales, marketing, and service teams. Node enables users of business applications to see into the future. Powered by Artificial Intuition™ technology, Node is the first turnkey AI-as-a-service platform focused on powering predictable business outcomes, which enterprises can use to quickly and seamlessly build advanced AI into both customer-facing and internal applications without investing years and millions of dollars on risky AI experiments. Applications powered by Node can deliver predictions that enable users to make smarter connections and decisions about how to engage with customers, employees, investors, and partners. Node was founded by Google's youngest employee, Falon Fatemi, and it's renowned technology team includes the Godfather of Search, Louis Monier who created Alta Vista, and Michael Radovancevich former CTO of Taleo and OpenX. Node is backed by Mark Cuban, NEA, Avalon Ventures, and JetBlue Technology Ventures.

BioEclipse Therapeutics

Series A in 2019
BioEclipse Therapeutics is a clinical-stage oncology company that develops immuno-oncology therapeutics using its proprietary technology. Its mission is to improve clinical outcomes and the quality of life for all cancer patients and to be at the forefront of turning cancer into a curable disease. The company has harnessed a refined understanding of the human immune system, gaining insights into the reasons the body’s defense system so often turns a blind eye to the presence of cancerous cells and tumors. In response, BioEclipse Therapeutics pairs activated immune cells with an adapted oncolytic virus that selectively infects and kills malignant cells.

Bitwise Industries

Series A in 2019
Bitwise Industries moves Fresno’s technology ecosystem forward by focusing on the key areas of education, execution, and place. Education is delivered via Geekwise Academy, an accelerated training program providing real-world technology skills to all ages. Bitwise Industries provides execution by way of its full-service, custom software development firm, Shift3 Technologies. Bitwise Industries also offers paid apprenticeships to students to help them learn tech skills, connect them to meaningful tech opportunities, and build vibrant buildings in underserved cities to house their work.

One Concern

Series B in 2019
One Concern is a climate resilience technology company, enables organizations to focus on adaptation and resilience strategies by using newly developed resilience analytics for supporting risk selection, mitigation, pricing and risk management. Applying machine learning and state-of-the-art resilience modeling, One Concern helps organizations better understand and prepare for physical climate risks with the mission of making disasters less disastrous. A 2019 Technology Pioneer, One Concern is part of the World Economic Forum’s Global Innovators community.

Markable Creators

Series A in 2019
BCG reported that 70% of Gen Z discover products through content platforms, not directly on a retailer website. Social commerce is NOW. The global fashion E-commerce digital advertising allocation is $200 billion. Mai is making social visual discovery shopping a reality on every photo and video across any social platforms or devices. Viewers can click and shop the clothing they see while watching videos, such as TV shows, movies, and other digital media. Mai bridges the gap between social content and e-commerce, through a fully-automated AI computer vision technology, a sophisticated e-commerce bidding system, and a user personalization system. At Mai, we have spent three years working with top computer vision AI scientists, AI engineers, and fashion experts that created the world’s 1st fully automated video fashion shopping solution. We are connected with numerous top global e-commerce platforms, with total 200M SKUs available, daily updated with an out-of-stock rate <3%. Moreover, Mai is already live with two of the biggest social content platforms in Asia, with more to come. Mai has won the No.1 winner of MIT AI Idol contest in Jul 2020, and also won the title of “Most fundable company by investment value” at the biggest Asia Internet Conference in Nov 2020.

Ketos

Series A in 2019
KETOS is a vertically integrated water intelligence platform with intelligent hardware, bi-directional connectivity infrastructure, interactive software, and hassle-free services, all for a predictable, flat service fee. The company provides hardware and software analytics solutions and real-time data for usage and flow across water systems and monitors water health parameters such as pH, dissolved solids, hardness, turbidity, and salinity.

Mammoth Biosciences

Series A in 2018
Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. Mammoth Biosciences aims to democratize disease detection with an easy and affordable point-of-care test that allows real-time and simultaneous detection of multiple conditions. By leveraging its internal research and development and exclusive licensing to Cas12, Cas13, and Cas14, Mammoth Biosciences can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in South San Francisco, Mammoth Biosciences is co-founded by CRISPR pioneer Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Mayfield, NFX, and 8VC, Decheng Capital and leading individual investors including Brook Byers, Tim Cook, and Jeff Huber. Mammoth has also been working on developing a rapid COVID-19 test.

Aclima

Series A in 2018
Aclima is a climate-tech company that focuses on mapping and analyzing air pollution through advanced measurement and analysis platforms. Aclima measures air pollution and greenhouse gases at unprecedented scales and block-by-block resolution. Their professional analytics software, Aclima Pro, translates billions of scientific measurements into environmental intelligence for governments, companies, and communities. Aclima is a purpose-driven technology company catalyzing bold climate action that protects public health, reduces emissions, and delivers clean air for all—investors, including Social Capital, Kapor Capital, and the Microsoft Climate Innovation Fund back them.

Shine

Series A in 2018
Shine is a developer of a self-care communication application designed to make well-being accessible. Their application is a messaging bot that gives out life advice and positive reinforcements including actionable tips based on confidence, daily happiness, mental health, productivity, and self-care audio challenges to grow on the go through sms texts on a daily basis, enabling people with anxiety and depression to get career and life advice to take proper care of themselves.

BioEclipse Therapeutics

Seed Round in 2018
BioEclipse Therapeutics is a clinical-stage oncology company that develops immuno-oncology therapeutics using its proprietary technology. Its mission is to improve clinical outcomes and the quality of life for all cancer patients and to be at the forefront of turning cancer into a curable disease. The company has harnessed a refined understanding of the human immune system, gaining insights into the reasons the body’s defense system so often turns a blind eye to the presence of cancerous cells and tumors. In response, BioEclipse Therapeutics pairs activated immune cells with an adapted oncolytic virus that selectively infects and kills malignant cells.

Vyv

Venture Round in 2018
Vital Vio offers a new class of antimicrobial light for infection and germ control through safe, continuous LED products. Our goal is to protect as many people and places from germs as possible with our products which can be utilized anywhere a light can fit. We service customers in food processing, healthcare, industrial/commercial as well as a licensing model for consumer and residential products.

Vow To Be Chic

Venture Round in 2017
Vow To Be Chic offers designer bridesmaid dress & Little White Dress rentals online, bringing cost savings and convenience to the bridesmaid experience. The total cost of being a bridesmaid averages $1,700, not to mention the countless hours spent planning and attending various events. Spending a few hundred dollars to buy a bridesmaid dress that will be worn only once is a source of tension between brides and bridesmaids. Coordinating dress selection, fitting, and purchasing for multiple bridesmaids located across the country also poses significant challenges.

ThinkCERCA

Series B in 2017
ThinkCERCA’s personalized literacy platform helps educators teach critical thinking skills through argumentative writing. With students and teachers using its platform in all 50 states and 130 countries, the company has partnered with prominent education leaders, including Follett Corporation, and has been featured by The Atlantic and EdSurge. A 2016 SIAA CODiE Awards finalist in the Best Learning Capacity-Building Solution and Best Reading/English/Language Arts Instructional Solution categories, ThinkCERCA has also been named one of the best tools in ed tech by Common Sense’s Graphite. In July 2013, ThinkCERCA was the recipient of a Bill & Melinda Gates Foundation Literacy Courseware Challenge grant, and in December 2012, graduated from the inaugural class of Impact Engine’s social impact accelerator. To learn more, please visit ThinkCERCA.com

Tinkergarten

Series A in 2017
Tinkergarten® provides the best early childhood education in the healthiest classroom of all—the outdoors. We match families with leaders in their local community who offer activity-based kids classes that help them develop the skills that matter most—all while having fun!

Markable Creators

Venture Round in 2017
BCG reported that 70% of Gen Z discover products through content platforms, not directly on a retailer website. Social commerce is NOW. The global fashion E-commerce digital advertising allocation is $200 billion. Mai is making social visual discovery shopping a reality on every photo and video across any social platforms or devices. Viewers can click and shop the clothing they see while watching videos, such as TV shows, movies, and other digital media. Mai bridges the gap between social content and e-commerce, through a fully-automated AI computer vision technology, a sophisticated e-commerce bidding system, and a user personalization system. At Mai, we have spent three years working with top computer vision AI scientists, AI engineers, and fashion experts that created the world’s 1st fully automated video fashion shopping solution. We are connected with numerous top global e-commerce platforms, with total 200M SKUs available, daily updated with an out-of-stock rate <3%. Moreover, Mai is already live with two of the biggest social content platforms in Asia, with more to come. Mai has won the No.1 winner of MIT AI Idol contest in Jul 2020, and also won the title of “Most fundable company by investment value” at the biggest Asia Internet Conference in Nov 2020.

Cordex Systems

Series A in 2017
Cordex Systems designs and manufactures a cardiovascular diagnostic device. Its product includes the Cordex EnDys System is a diagnostic tool that provides both early detection and ongoing monitoring of cardiovascular disease by measuring endothelial dysfunction.

EpiBone

Convertible Note in 2016
EpiBone is a pioneering regenerative medicine company at the forefront of bone and cartilage repair. Leveraging the power of stem cells, biomimicry, and 3D fabrication, they are developing a pipeline of innovative products with enormous potential to revolutionize orthopedic repair. Their lead product, a living, anatomically precise 3D bone graft, completed its Phase I/IIa clinical trial in August 2023. The rest of their pipeline focuses on cartilage repair, and includes an allogeneic osteochondral plug, whose IND was approved in July 2023. Their cartilage portfolio also includes an injectable cartilage filler that was partly funded by the Department of Defense.

Tinkergarten

Seed Round in 2016
Tinkergarten® provides the best early childhood education in the healthiest classroom of all—the outdoors. We match families with leaders in their local community who offer activity-based kids classes that help them develop the skills that matter most—all while having fun!

Talent Sonar

Series A in 2016
TalentSonar merged with TalVista which helps companies manage unconscious bias for improved diversity hiring with redacted resume review, job description optimization, and structured interviews.

Trustify

Seed Round in 2015
Trustify makes truth, trust and safety accessible to everyone through its network of licensed private investigators and intel analysts
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.